Skip to main content
. 2021 Dec 4;40:383. doi: 10.1186/s13046-021-02193-1

Table 1.

miRNAs in cancer therapeutics

Target Drug name Cancer Phase ClinicalTrials.gov Identifier
Mir 16 TargomiRs Malignant pleura mesothelioma, Non small-cell lung cancer I NCT02369198
Mir 155 MRG 106 Lymphomas, Leukemia I NCT02580552
Mir 34a MRX34 Melanoma, Primary liver cancer; Hematologic malignancies I Terminated NCT01829971
Mir 34a MRX34 Melanoma, Primary liver cancer; Hematologic malignancies I/II Withdrawn NCT02862145